Metabolon is partnering with multiple clinical, biopharma and population health organizations to build the world’s largest metabolomics database, reveal novel biomarker discoveries and advance clinical metabolomics for precision medicine.
Let’s discuss how we can advance your proprietary programs.
A trusted partner for 20 years
1,300+ clients. 10,000 projects. Learn why researchers around the world have put their trust in Metabolon for two decades.
“At Siolta, we are utilizing both untargeted and targeted metabolomic approaches to help characterize the overall metabolic signatures associated with treatment and response and potentially provide insight into patient stratification for more precise therapeutic approaches moving forward.”
“Living in a microscopic world, cells communicate with each other by speaking in small molecules. We’re seeing a conversation happen between the microbiome and body, and metabolomics allows us to listen to the language spoken by the microbiome to the body.”